| Patient | John F. Kennedy |
|---|---|
| Date of birth | 1995-05-29 |
| Identifiers | MRN HR-ML023-SYN; SSN (made up) 000-23-5408 |
| Document date | 2026-01-12 |
| Author | Harlan Prescott, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
The patient attends this visit for establishing primary care about three months after primary adrenal insufficiency was diagnosed during an adrenal crisis abroad: replacement doses, electrolytes and renin, cause, autoimmune screening, sick-day rules and emergency kit, and chronic low back pain. [S]
Hemoglobin: 13.6 g/dL; Sodium: 134 mmol/L (low); Potassium: 5.2 mmol/L (high); Creatinine: 0.96 mg/dL; eGFR: 109 mL/min/1.73 m²; Fasting glucose: 84 mg/dL; Plasma renin activity: 9.6 ng/mL/h (high); 21-hydroxylase antibodies: 18 U/mL (high); TSH: 7.4 mIU/L (high); Free T4: 1 ng/dL; Thyroid peroxidase antibodies: 286 [IU]/mL (high); Vitamin B12: 455 pg/mL; Hemoglobin A1c: 5.1%; Tissue transglutaminase IgA: 1.1 U/mL; Total IgA: 214 mg/dL; 25-hydroxyvitamin D: 31 ng/mL; PHQ-9: 4; Oswestry Disability Index: 32. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-01-12 | Body height | 183 | cm | S |
| 2026-01-12 | Body weight | 66 | kg | S |
| 2026-01-12 | Body mass index (BMI) [Ratio] | 19.7 | kg/m2 | S |
| 2026-01-12 | Systolic blood pressure | 104 | mm[Hg] | S |
| 2026-01-12 | Diastolic blood pressure | 66 | mm[Hg] | S |
| 2026-01-12 | Heart rate | 88 | /min | S |
| 2026-01-12 | Respiratory rate | 16 | /min | S |
| 2026-01-12 | Body temperature | 36.6 | Cel | S |
| 2026-01-12 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-01-12 | Hemoglobin [Mass/volume] in Blood | 13.6 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 2026-01-12 | Sodium [Moles/volume] in Serum or Plasma | 134 | mmol/L | 135-145 mmol/L | Low | S |
| 2026-01-12 | Potassium [Moles/volume] in Serum or Plasma | 5.2 | mmol/L | 3.5-5.1 mmol/L | High | S |
| 2026-01-12 | Creatinine [Mass/volume] in Serum or Plasma | 0.96 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-01-12 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 109 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-01-12 | Fasting glucose [Mass/volume] in Serum or Plasma | 84 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-01-12 | Renin [Enzymatic activity/volume] in Plasma | 9.6 | ng/mL/h | Upright, mid-morning: 0.6 to 4.3 ng/mL/h | High | S |
| 2026-01-12 | 21-Hydroxylase Ab [Units/volume] in Serum | 18 | U/mL | Below 1 U/mL: negative | High | S |
| 2026-01-12 | Thyrotropin [Units/volume] in Serum or Plasma | 7.4 | m[IU]/L | 0.45-4.5 mIU/L | High | S |
| 2026-01-12 | Thyroxine (T4) free [Mass/volume] in Serum or Plasma | 1 | ng/dL | 0.8-1.8 ng/dL | Normal | S |
| 2026-01-12 | Thyroperoxidase Ab [Units/volume] in Serum or Plasma | 286 | [IU]/mL | <=34 [IU]/mL | High | S |
| 2026-01-12 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 455 | pg/mL | 232-1245 pg/mL | Normal | S |
| 2026-01-12 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.1 | % | Below 5.7% is normal; 5.7 to 6.4% prediabetes | Normal | S |
| 2026-01-12 | Tissue transglutaminase IgA Ab [Units/volume] in Serum | 1.1 | U/mL | Below 4 U/mL: negative | Normal | S |
| 2026-01-12 | IgA [Mass/volume] in Serum or Plasma | 214 | mg/dL | 70-400 mg/dL | Normal | S |
| 2026-01-12 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 31 | ng/mL | 30-100 ng/mL | Normal | S |
| 2026-01-12 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 2026-01-12 | Oswestry disability index score ODI | 32 | {score} | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Hydrocortisone 10 mg oral tablet, two tablets (20 mg) on waking and one tablet (10 mg) at 2 pm, 30 mg a day (started in hospital) | Two tablets on waking and one tablet at 2 pm | Oral route | 2025-10-06 to 2026-01-26 | completed | S |
| Fludrocortisone 0.1 mg oral tablet, half a tablet (0.05 mg) by mouth once daily (started in hospital) | Half a tablet by mouth once daily | Oral route | 2025-10-06 to 2026-01-26 | completed | S |
| Hydrocortisone 100 mg injection kit (with diluent), 100 mg into the thigh muscle once for vomiting, collapse or signs of adrenal crisis, then call 911 | Once, as needed for adrenal crisis; carry at all times | Intramuscular route | 2026-01-12 | active | S |
| Acetaminophen 500 mg oral tablet, two tablets by mouth up to three times a day as needed for back pain | Two tablets up to three times a day as needed | Oral route | 2026-01-12 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Primary adrenal insufficiency (Addison's disease), diagnosed about three months ago during an adrenal crisis while traveling abroad, on hydrocortisone and fludrocortisone; synthetic modern episode linked to his documented 1947 diagnosis | active | confirmed | E27.1 | S — Synthetic modern coding of the documented diagnosis. |
| Chronic low back pain persisting after lumbar disc surgery; began after a football injury in college and worsened during wartime naval service; uses a corset brace; synthetic modern episode linked to his documented back history | active | confirmed | M96.1 | S — Synthetic modern coding of the documented back pain and operation. |
| Raised TSH with positive thyroid peroxidase antibodies and normal free T4 on screening for associated autoimmune disease; to be repeated before any treatment | active | confirmed | R94.6 | S — Synthetic screening finding. |